The research and development lab will employ a team of metabolic engineers, precision fermentation specialists, automation experts, and analytical support. The facility will be home to DMC’s workflows in strain and metabolic engineering, high throughput testing, as well as bench and pilot scale fermentation. The facility complements DMC’s Boulder facility, which manages the company’s downstream separation and purification development activities.

DMC’s precision fermentation bioprocess leverages its proprietary Dynamic Metabolic Control technology and enables the production of low-carbon and economical chemicals.

Kenny Erdoes, DMC CEO commented, “We are proud to announce the opening of our new laboratory in North Carolina. This new facility will support a growing team and enable us to bring online additional capabilities and streamline existing workflows to accelerate the development of new sustainable chemical solutions.”

North Carolina currently ranks among the top three US states for bioscience employment and is a leader in vaccine research and manufacturing.